User profiles for Suveer Singh

suveer singh

Consultant in Respiratory and Critical Care Medicine, Honorary Clinical Senior Lecturer …
Verified email at imperial.ac.uk
Cited by 5091

Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations

…, C Morgan, M Passariello, S Price, S Singh… - American journal of …, 2020 - atsjournals.org
Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have accrued
rapidly since the outbreak, but few address the underlying pathophysiology. Objectives: To …

Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial

PL Shah, Z Zoumot, S Singh, SR Bicknell… - The Lancet …, 2013 - thelancet.com
Background Few treatment options exist for patients with severe emphysema. We assessed
the clinical benefits and safety of lung volume reduction coils (LVRCs) for the treatment of …

[HTML][HTML] Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method

…, MJ Schultz, M Shankar-Hari, S Singh… - Critical Care, 2021 - Springer
Background Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented
pressure on healthcare system globally. Lack of high-quality evidence on the respiratory …

A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae

…, F Kamal, WDC Man, S Kaul, S Singh… - Science translational …, 2022 - science.org
Interstitial lung disease and associated fibrosis occur in a proportion of individuals who have
recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Right ventricular dysfunction in critically ill COVID-19 ARDS

C Bleakley, S Singh, B Garfield, M Morosin… - International Journal of …, 2021 - Elsevier
Aims Comprehensive echocardiography assessment of right ventricular (RV) impairment has
not been reported in critically ill patients with COVID-19. We detail the specific phenotype …

Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy

…, CP Denton, VH Ong, S Singh… - European …, 2012 - Eur Respiratory Soc
In very severe interstitial lung disease associated with connective tissue disease (CTD-ILD),
progressing despite maximal conventional immunosuppression, there is no effective …

Performing bronchoscopy in times of the COVID-19 pandemic: practice statement from an international expert panel

F Luo, K Darwiche, S Singh, A Torrego, DP Steinfort… - Respiration, 2020 - karger.com
… Fengming Luoa Kaid Darwicheb Suveer Singhc–e Alfonso Torregof Daniel P. Steinfortg,
h Stefano Gasparinii Dan Liua Wei Zhangj Sebastian Fernandez-Bussyk Felix JF Herthl, m …

[HTML][HTML] Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation

…, TS Walsh, N Anderson, AC Morris, S Singh… - The Lancet …, 2020 - thelancet.com
Background Ventilator-associated pneumonia is the most common intensive care unit (ICU)-acquired
infection, yet accurate diagnosis remains difficult, leading to overuse of antibiotics. …

Increased dolutegravir peak concentrations in people living with human immunodeficiency virus aged 60 and over, and analysis of sleep quality and cognition

ER Elliot, X Wang, S Singh, B Simmons… - Clinical Infectious …, 2019 - academic.oup.com
Background Demographic data show an increasingly aging human immunodeficiency virus
(HIV) population worldwide. Recent concerns over dolutegravir-related neuropsychiatric …

Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia

…, DF McAuley, TS Walsh, NH Anderson, S Singh… - Thorax, 2015 - thorax.bmj.com
Background Excessive use of empirical antibiotics is common in critically ill patients. Rapid
biomarker-based exclusion of infection may improve antibiotic stewardship in ventilator-…